Phibro Animal Health (PAHC) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Phibro Animal Health Corporation  (NASDAQ: PAHC)

Select the Financial Report: Select the Period:


Description of Phibro Animal Health's Business Segments


Phibro Animal Health Corporation Overview:

Phibro Animal Health Corporation is a prominent player in the animal health and nutrition sector, renowned for its commitment to enhancing the health, productivity, and well-being of animals globally. The company operates through three main segments: Animal Health Products, Nutrition Products, and Performance Products. Below is an extensive description of each segment, along with the specific products and services offered within them.

1. Animal Health Products:

Phibros Animal Health Products segment provides an extensive array of solutions that address the health needs of livestock and poultry. This segment includes:

- Vaccines: A core component of the animal health product line, Phibro develops various vaccines aimed at preventing infectious diseases in livestock and poultry. These vaccines are formulated to protect against a range of pathogens, ensuring immunity and reducing the incidence of disease outbreaks.

- Parasiticides: Phibro offers products designed to control and eliminate parasites that can adversely affect animal health and productivity. These include anthelmintics for internal parasites and ectoparasiticides for external threats. The products are essential for maintaining the overall health of animals by preventing diseases caused by parasitic infestations.

- Antimicrobials: The company provides a selection of antimicrobial products that target bacterial infections specific to different species. These products play a critical role in disease management by ensuring that livestock and poultry can recover from infections while minimizing the risk of antibiotic resistance through responsible use.

- Other Health Products: This category encompasses a variety of products aimed at promoting animal wellness. These may include therapies for respiratory ailments, gastrointestinal disorders, and other health challenges commonly faced by livestock and poultry.

Nutrition Products:

The Nutrition Products segment focuses on optimizing animal health through enhanced nutritional formulations. Key offerings include:

- Feed Additives: Phibro develops a range of feed additives that promote growth, improve feed efficiency, and enhance the overall quality of feeds. These additives may include probiotics, prebiotics, enzymes, and various nutritional supplements tailored to different species.

- Specialty Ingredients: The company provides specialty ingredients that serve specific functional purposes in animal feeds. These ingredients are designed to maintain gastrointestinal health, improve nutrient absorption, and optimize metabolic processes.

- Premixes: Phibro’s premixes are formulated to deliver balanced nutrition to livestock and poultry. These premixes can be customized to meet specific dietary requirements based on the type of animal, their production phase, and the desired outcomes, such as weight gain or improved reproductive performance.

Performance Products:

Phibro’s Performance Products segment is dedicated to maximizing efficiency and productivity in animal production systems. This segment includes:

- Productivity Enhancers: Phibro offers a variety of productivity-enhancing products that are scientifically formulated to improve overall animal performance. This includes products designed to increase feed conversion rates, optimize growth rates, and enhance reproductive efficiency.

- Specialty Ingredients: Like in the Nutrition segment, specialty ingredients in the Performance segment are aimed at supporting animal health while maximizing output. This includes products that enhance metabolic functions and overall physiological responses to feeding.

- Research and Development Support: Phibro invests in R&D to continually innovate and refine its product offerings. The company collaborates with academic institutions and industry partners to develop cutting-edge technologies that address emerging health and nutritional challenges in animal agriculture.

Conclusion:

Phibro Animal Health Corporation is well-known for its comprehensive and innovative approach to animal health and nutrition. Through its three distinct segments—Animal Health Products, Nutrition Products, and Performance Products—the company provides an extensive portfolio designed to support the health, growth, and productivity of livestock and poultry. By understanding and addressing the specific needs of animals, Phibro plays a critical role in supporting producers worldwide, helping them achieve optimal animal health and production outcomes.


Composition of Phibro Animal Health Corporation Revenues by Segments

 
Medicated Feed Additives and Others    204.34 % of total Revenue
Nutritional Specialties    49.17 % of total Revenue
Vaccines    39.43 % of total Revenue
Animal Health    292.94 % of total Revenue
Mineral Nutrition    71.16 % of total Revenue
Performance Products    18.53 % of total Revenue
US    221.08 % of total Revenue
Latin America and Canada    85.87 % of total Revenue
EMEA    47.37 % of total Revenue
Asia Pacific    28.32 % of total Revenue

Q4 three months ended (Jun 30 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Medicated Feed Additives and Others 810.73 204.34 %
Nutritional Specialties 195.07 49.17 %
Vaccines 156.42 39.43 %
Animal Health 1,162.22 292.94 %
Mineral Nutrition 282.34 71.16 %
Performance Products 73.53 18.53 %
US 877.13 221.08 %
Latin America and Canada 340.67 85.87 %
EMEA 187.94 47.37 %
Asia Pacific 112.36 28.32 %
Total 396.75 100 %




Q4 three months ended (Jun 30 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Medicated Feed Additives and Others - -
Nutritional Specialties - -
Vaccines - -
Animal Health - 299.08 %
Mineral Nutrition - 284.57 %
Performance Products - 289.06 %
US - -
Latin America and Canada - -
EMEA - -
Asia Pacific - -
Total -69.39 % 3.68 %




Q4 three months ended (Jun 30 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total 21.71 5.47 %




Q4 three months ended (Jun 30 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total -55.02 % -9.63 %




Annual Report on Phibro Animal Health Corporation Divisions, Sales by Country

 
Animal Health   Animal Health Segment contribution to total sales 74.29 % of total Revenue
Mineral Nutrition   Mineral Nutrition Segment contribution to total sales 19.54 % of total Revenue
Performance Products   Performance Products Segment contribution to total sales 6.19 % of total Revenue


Twelve months ended 2025
PAHC s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Animal Health 962.80 74.29 %
Mineral Nutrition 253.24 19.54 %
Performance Products 80.18 6.19 %
Total 1,295.94 100 %


Twelve months ended 2025
PAHC s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total 48.26 3.72 %

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Animal Health 36.28 % -
Mineral Nutrition 3.93 % -
Performance Products 18.72 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.